News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

Opinion|Videos|August 28, 2024

Early Diagnosis and Treatment for Central Precocious Puberty

Author(s)Karen O. Klein, MD, Jill Samis, MD , Aviva B. Sopher, MD, MS

The panel explores the impact of early versus delayed diagnosis and treatment initiation on long-term outcomes in Central Precocious Puberty patients.

Episodes in this series

3 KOLs are featured in this series.

EP. 1 Overview Of Central Precocious Puberty

3 KOLs are featured in this series.

EP. 2 Diagnosis of Central Precocious Puberty and its Psychosocial Impact

3 KOLs are featured in this series.

EP. 3 Early Diagnosis and Treatment for Central Precocious Puberty

3 KOLs are featured in this series.

EP. 4 Treatment Options for Central Precocious Puberty

3 KOLs are featured in this series.

EP. 5 Safety and Efficacy of GnRHa Treatments in Central Precocious Puberty

3 KOLs are featured in this series.

EP. 6 Individualized Management of Central Precocious Puberty

3 KOLs are featured in this series.

EP. 7 Central Precocious Puberty Treatment Starts, Discontinuations and Misconceptions

3 KOLs are featured in this series.

EP. 8 Central Precocious Puberty in Male Patients

3 KOLs are featured in this series.

EP. 9 Recommendations and Outlook for Central Precocious Puberty

Video content above is prompted by the following:

How might an early CPP diagnosis and subsequent treatment initiation affect outcomes, compared to a later start?

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Chronicity, Symptom Variability, and Treatment Expectations in Pediatric Functional Constipation and IBS-C

ByJulie Khlevner, MD, AGAF

June 17th 2026

4 Experts are featured in this series

RSV Monoclonal Antibodies: Mechanisms of Action and How to Explain Them to Families

ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

June 15th 2026

4 Experts are featured in this series

RSV Prevention Overview: Maternal Vaccines and Monoclonal Antibodies

ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

June 15th 2026

Distinguishing Functional Constipation From IBS-C and Embracing a Positive Diagnosis

ByJulie Khlevner, MD, AGAF

June 11th 2026

4 Experts are featured in this series

RSV Diagnosis: Why Specific Testing Matters for RSV Management

ByFlor M. Munoz, MD, MSc,C. Buddy Creech, MD, MPH,Eric Simões, MD,Tina Q. Tan, MD, FAAP, FIDSA, FPIDS

June 8th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Chronicity, Symptom Variability, and Treatment Expectations in Pediatric Functional Constipation and IBS-C

FDA issues Warning Letter to SNOO Smart Sleeper maker over unauthorized sleep sacks, hospital bundle, and quality system failures

Empowering underserved children through representation, health literacy, and trusted content

Weekly review: Formula recall, FDA warning for bassinet, and more

Cadrenal plans FDA rare pediatric disease request for tecarfarin in Kawasaki disease